ABSTRACT

Cardiovascular diseases (CVDs) deserve more clinical attention being the primary clinical outcome of metabolic syndrome (MetS). Indians are highly predisposed to MetS, insulin resistance and CVDs. Lipoprotein (a) Lp(a) is a emerging risk factors in the development of CVDs. Lp(a) is an independent determinant of aortic stiffness in elderly patients with diabetes. Type 2 DM is a worldwide endemic disease. Dyslipidemia is also a frequent disorder associated with diabetic patients. Lipid profiles can vary in Diabetes and metabolic syndrome patients. We investigated serum lipid profiles, Lp(a) levels in metabolic syndrome and in type 2 diabetic patients. In this study 220 type 2 diabetic patients and 220 metabolic syndrome patients and 220 healthy control subjects were included. After 12 hours overnight fasting, blood samples were obtained for analyzing the serum lipids, FBS and HbA1C. Type 2 diabetic patients had higher serum total cholesterol, LDL cholesterol, triglyceride and Fasting blood sugar and HBA1C levels and lesser HDL-cholesterol, compared with the Metabolic Syndrome and control group.In
Publication date: 1/1/21

https://ijbpas.com/pdf/2021/January/MS_IJBPAS_2021_JAN_SPCL_1022.pdf

Download PDF
https://doi.org/10.31032/IJBPAS/2021/10.1.1022